Codeine camphosulphonate / sodium benzoate, codeine camphosulphonate...:CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00010542/201912
(PDF/104.05 KB)
Last updated: 10/11/2020
Active substance: codeine camphosulphonate / sodium benzoate, codeine camphosulphonate / sulfogaiacol / grindelia soft extract
Procedure number: PSUSA/00010542/201912
Regulatory outcome: Variation